CD34 and coronary artery disorder: The percentage of CD34+ cells within harvested bone marrow and CD34+ cell mobility in an SDF-1 gradient was compared with and without autologous serum in age-matched healthy volunteers free from any symptomatic coronary artery disease (N = 10) and patients participating in our trial (N = 6).